Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))

Ralph A. Defronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl

Producción científica: Comment/debate › revisión exhaustiva

1 Cita (Scopus)

Huella

Profundice en los temas de investigación de 'Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))'. En conjunto forman una huella única.